Skip to main navigation
Skip to search
Skip to main content
Sort by
Pharmacology, Toxicology and Pharmaceutical Science
Bloodstream Infection
100%
Infection
42%
Staphylococcus aureus
27%
Penicillinase
25%
Antimicrobial Therapy
25%
Escherichia coli
21%
Extended Spectrum Beta Lactamase
20%
Klebsiella pneumoniae
19%
Pseudomonas aeruginosa
18%
Infectious Agent
18%
Vancomycin
18%
Mortality Rate
18%
Ciprofloxacin
17%
Clinical Feature
17%
Diseases
16%
Antimicrobial Resistance
16%
Methicillin-Resistant Staphylococcus Aureus
15%
Enterococcus faecium
15%
Acute Pyelonephritis
14%
Malignant Neoplasm
13%
Prevalence
12%
Methicillin Resistant Staphylococcus Aureus Infection
12%
Escherichia Coli Pneumonia
12%
Extended Spectrum Beta Lactamase Producing Escherichia Coli
11%
Imipenem
11%
Cohort Study
11%
Gram Negative Bacterium
11%
Antiinfective Agent
11%
Meticillin
10%
Streptococcus pneumonia
10%
Antibiotics
10%
Carbapenem
10%
Levofloxacin
9%
Hematologic Malignancy
9%
Case-Control Study
9%
Staphylococcal Bacteremia
9%
Healthcare Associated Infection
9%
Cephalosporin
9%
Surgical Infection
9%
Bacterial Peritonitis
9%
Teicoplanin
9%
Vancomycin-Resistant Enterococcus
8%
Gram Negative Sepsis
8%
Quinolone Derivative
8%
Enterobacter
7%
Septic Shock
7%
Colistimethate
7%
Staphylococcal Infection
7%
Rifampicin
7%
Acinetobacter
7%
Medicine and Dentistry
Bloodstream Infection
67%
Infection
38%
Penicillinase
32%
Pneumococcal Pneumonia
24%
Extended Spectrum Beta Lactamase
24%
Streptococcus pneumonia
23%
Escherichia coli
20%
Antimicrobial Therapy
17%
Middle East Respiratory Syndrome
14%
Klebsiella pneumoniae
14%
Pathogen
13%
Cohort Effect
13%
Mortality Rate
12%
Antibiotic Resistance
12%
Escherichia Coli Pneumonia
11%
Odds Ratio
11%
Extended Spectrum Beta Lactamase Producing Escherichia Coli
11%
Levofloxacin
10%
Clinical Feature
10%
Staphylococcus aureus
9%
Catheter Infection
9%
Serotype
9%
Prevalence
9%
Enterobacter
9%
COVID-19
9%
Blood Culture
9%
Ciprofloxacin
9%
Diseases
8%
Molecular Epidemiology
8%
Multivariate Analysis
8%
Malignant Neoplasm
7%
Cephalosporin Resistance
7%
Cohort Analysis
7%
Methicillin Resistant Staphylococcus Aureus
7%
Gram-Negative Bacteria
7%
Staphylococcal Bacteremia
7%
Public Health
7%
Septic Shock
7%
Kidney Graft
7%
Quinolone Derivative
7%
Latent Tuberculosis
7%
Surgical Infection
7%
Middle East Respiratory Syndrome Coronavirus
7%
Case-Control Study
6%
Hematologic Malignancy
6%
Antibiotics
6%
Carbapenem
6%
Gram Negative Sepsis
6%
Sepsis
6%
Antiinfective Agent
5%
Immunology and Microbiology
Escherichia coli
39%
Staphylococcus aureus
32%
Methicillin-Resistant Staphylococcus Aureus
31%
Klebsiella pneumoniae
30%
Infectious Agent
27%
Mortality Rate
22%
Prevalence
22%
Pseudomonas aeruginosa
21%
Serotype
20%
Extended Spectrum Beta Lactamase Producing Escherichia Coli
19%
Streptococcus pneumonia
16%
Antimicrobial Resistance
15%
Enterococcus faecium
15%
Vancomycin-Resistant Enterococcus
14%
Minimum Inhibitory Concentration
12%
Enterobacter
11%
Methicillin Susceptible Staphylococcus Aureus
11%
Molecular Epidemiology
10%
Severe Acute Respiratory Syndrome Coronavirus 2
10%
Gram-Negative Bacteria
10%
Inoculum
9%
Plasmid
8%
Abscess
8%
Antibiotic Sensitivity
8%
Cephalosporin Resistance
7%
Multilocus Sequence Typing
7%
Gene Mutation
7%
Immunosuppressant
7%
Urinary Tract
7%
Omicron Coronavirus Variant
7%
Vancomycin Intermediate Staphylococcus Aureus
7%
Hematopoietic Stem Cell Transplantation
7%
Colistin
7%
Multidrug Resistance
6%
C-Reactive Protein
6%
COVID-19
6%
Stenotrophomonas maltophilia
5%
Microorganism
5%
Methicillin Resistance
5%
Adoptive Immunity
5%
Pneumococcus
5%
Titer
5%
Endocarditis
5%